2023-05-26 03:13:02 ET
- Mesoblast press release ( NASDAQ: MESO ): Q3 GAAP EPS of -$0.025 beats by $0.13 .
- Revenue of $1.94M (-3.0% Y/Y) misses by $0.18M .
- Cash on hand at the end of the quarter of $48.8 million, pro-forma cash after adjusting for $40.0 million of proceeds raised in April is $88.8 million, with up to an additional $40.0 million available to be drawn down from existing financing facilities subject to certain milestones.
- Net cash usage for operating activities in the quarter was $16.2 million; this represented an increase of $0.7 million, or 4%, on the comparative quarter in FY2022, and a reduction of $8.3 million, or 34%, on the comparative quarter in FY2021.
For further details see:
Mesoblast GAAP EPS of -$0.025 beats by $0.13, revenue of $1.94M misses by $0.18M